IML Implements
iLab Solutions

The CHiiPs core lab (IML) began using the iLab Solutions core lab management system on September 19.

The vision of The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs) is to become a leader in the field of human immunology by establishing an environment where basic, translational and clinical aspects of human immunology and immunotherapy research are seamlessly integrated.   We will achieve this through these primary initiatives:

  • Facilitate basic research in the new and rapidly evolving areas of human immunology;
  • Use the insights that emerge from this research to achieve a better understanding of human disease; and,
  • Provide an environment that encourages and supports the clinical translation of these insights into novel therapies for autoimmunity, cancer, immunodeficiency and infectious diseases.

Featured News

Washington University School of Medicine in St. Louis News

$10 million gift creates Bursky Center for Human Immunology and Immunotherapy

Washington University School of Medicine in St. Louis has received a $10 million gift to support research that harnesses the immune system to fight cancer, infectious diseases, and disorders caused by autoimmunity and immune deficiencies.

Read More
St. Louis Post Dispatch

Washington University gets $10 million for immune system research

Andrew and Jane Bursky donated $10 million to Washington University for its research on using the immune system to fight diseases including cancer. The gift creates the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs and an endowed distinguished professorship for cancer immunologist Robert Schreiber, director of the center and an adviser to Vice President Joe Biden's cancer moonshot project.

Read More

Upcoming Events

Translational Research Areas

Cancer

Immune Dysfunction

Infectious Disease & Vaccines

Immunomonitoring Lab (IML)

The IML provides state-of-the-art analyses to monitor immunologic changes occurring during immunotherapy and relate them to treatment outcomes.

LEARN MORE